BackGlobeStar Therapeutics Overview

GlobeStar Therapeutics Long Term Debt

Latest long-term debt for GSTC: $0.

Get informed when a big investor buys or sells

+ Follow
Long Term Debt
$0.00

Peer trimmed avg / median

Loading

GlobeStar Therapeutics Long Term Debt History

Loading

GlobeStar Therapeutics vs. peers: Long Term Debt Comparison

Loading

GlobeStar Therapeutics Long Term Debt Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

GlobeStar Therapeutics (GSTC) FAQ

GlobeStar Therapeutics (GSTC) currently reports a long-term debt of $0 as of June 2024. In the prior-year period, the figure was $0. Use the charts on this page to explore GlobeStar Therapeutics's long-term debt history and peer comparisons.

GlobeStar Therapeutics's long-term debt changed from $0 to $0 (period ending June 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

GlobeStar Therapeutics reported $0 in long-term debt as of June 2024. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current long-term debt of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for GlobeStar Therapeutics, and consider following GSTC for alerts when major investors trade the stock.

GlobeStar Therapeutics is classified in the Industrials sector. On long-term debt, it currently shows $0. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Industrials are usually more informative than comparing GSTC with unrelated industries.